Pacor M L, Biasi D, Carletto A, Lunardi C
Istituto di Clinica Medica, Università, Verona.
Recenti Prog Med. 1995 Dec;86(12):489-91.
We have evaluated the efficacy of oral hyposensitivization in 14 patients suffering from bronchial asthma due to allergy to Dermatophagoides pteronyssinus. The allergen extract was taken in increasing doses and the maximum dose was maintained for the duration of the study (two years). Oral treatment was effective in reducing the number and severity of asthma attacks (p < 0.001) and in improving the respiratory peak flow (p < 0.001). No side effects were observed and all the patients concluded the study. Our results show the efficacy and safety of oral hyposensitization in the treatment of bronchial asthma due to allergy to Dermatophagoides pteronyssinus. Oral therapy avoids the side effects of desensitizing injections which can be serious.
我们评估了口服减敏疗法对14例因对屋尘螨过敏而患支气管哮喘患者的疗效。变应原提取物剂量递增,最大剂量在研究期间(两年)维持不变。口服治疗在减少哮喘发作次数和严重程度方面有效(p < 0.001),并能改善呼吸峰值流速(p < 0.001)。未观察到副作用,所有患者均完成了研究。我们的结果显示口服减敏疗法治疗因对屋尘螨过敏所致支气管哮喘具有疗效和安全性。口服疗法避免了可能很严重的脱敏注射的副作用。